Background Conflicting evidence exists regarding the association between saturated fatty
acids (SFAs) and type 2 diabetes. In this longitudinal case-cohort study, we aimed to …

Background Combinations of multiple fatty acids may influence cardiometabolic risk more
than single fatty acids. The association of a combination of fatty acids with incident type 2 …

Background: Circulating saturated fatty acids (SFAs) are integrated biomarkers of diet and
metabolism that may influence the pathogenesis of diabetes. In epidemiologic studies …

Background The metabolic effects of omega-6 polyunsaturated fatty acids (PUFAs) remain
contentious, and little evidence is available regarding their potential role in primary …

Background Whether and how n-3 and n-6 polyunsaturated fatty acids (PUFAs) are related
to type 2 diabetes (T2D) is debated. Objectively measured plasma PUFAs can help to clarify …

Background Plasma odd-chain saturated fatty acids (OCFA) are inversely associated with
type 2 diabetes (T2D) risk and may serve as biomarkers for dairy fat intake. Their distribution …

The effect of saturated fatty acids (SFAs) on incident type 2 diabetes (T2D) is controversial
and few have systematically appraised the evidence. We conducted a comprehensive …

OBJECTIVE Prospective associations between n-3 fatty acid biomarkers and type 2 diabetes
(T2D) risk are not consistent in individual studies. We aimed to summarize the prospective …

Background: Epidemiologic evidence for the association between types of fatty acid and risk
of type 2 diabetes is inconsistent. This may in part be due to the limitations of fatty acid …

Background Data on saturated fatty acids (SFAs) in relation to metabolic function and
glucose homeostasis remain controversial. Such data are lacking among pregnant women …